ClinicalTrials.gg
Sign In

Hypoglycemia clinical trials

The registry lists 706 studies for Hypoglycemia across more than 10 countries. 94 are recruiting or about to start. 221 of them are mainly about Hypoglycemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Congenital Hyperinsulinism: 730 studies, 95 open.

ClinicalTrials.gov finds 966 studies for Hypoglycemia. How that becomes 706 here

This page counts the studies the registry files under Hypoglycemia, and those it files under no condition that list Hypoglycemiathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 966Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −23Filed under a narrower condition, counted on its own pageCongenital Hyperinsulinism 22 · Nesidioblastosis 1
  3. −50List Hypoglycemia as a condition, but the registry did not file them under itMost often written as “Neonatal Hypoglycemia” (15), “Hypoglycemia Unawareness” (12), and “Fear of Hypoglycemia” (5). The registry filed them under other conditions only, most often Diabetes Mellitus, Type 1 (20) and Premature Birth (7).
  4. −187Match it another way118 name it in the title, 17 in a keyword, and 52 by a synonym or other text the search reads.
  5. 706The count on this page42 of them list Hypoglycemia in their own words; the registry filed them under no condition.

Get an email when these change. Save the Hypoglycemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
457
Recruiting
59
Terminated
54
Status unknown
45
Withdrawn
32
Not yet recruiting
27

Phase

Phase 2
117
Phase 1
63
Phase 4
53
Phase 3
53
Early Phase 1
15

Where

United States
294
Canada
72
Denmark
63
United Kingdom
43
Switzerland
34
France
33

Who runs them

Institut de Recherches Cliniques de Montreal (27) · Steno Diabetes Center Copenhagen (17) · Joslin Diabetes Center (15) · University of Minnesota (13) · Insel Gruppe AG, University Hospital Bern (12) · Yale University (11) · Zealand Pharma (11) · Jaeb Center for Health Research (10)

What is being tested here

Drugs under test in Hypoglycemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Avexitide3110
Fluorodopa F 18202
Atropine202
Glucagon1730
Insulin Glargine119
Insulin Aspart118
Glucose116
Ersodetug124
Glucagon-Like Peptide 1104
Dapagliflozin104

Drug classes tested here SGLT2 inhibitors 1 open · GLP-1 receptor agonists 13 · DPP-4 inhibitors 12 · Bronchodilators 5 · Opioid antagonists 4

Coming up

6phase 3 studies under way
40studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 59 Hypoglycemia studies recruiting now, 23 (39%) set no upper age limit and 31 (53%) stop at 75 or younger. 18 (31%) take children under 18. 3 (5%) are for women only and 0 (0%) for men only; 14 (24%) take healthy volunteers.

Recruiting studies that take each age, of 59
AgeWomenMen
1012 (20%)12 (20%)
1849 (83%)46 (78%)
3047 (80%)44 (75%)
4047 (80%)44 (75%)
5043 (73%)41 (69%)
6541 (69%)39 (66%)
7531 (53%)29 (49%)
8527 (46%)25 (42%)

Across all 706 studies, recruiting or not: 58% stop at 75 or younger and 45% at 65; 23% take children; 3% are for women only and 4% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hypoglycemia studies take

Of 24 phase 2 interventional studies under Hypoglycemia, half reached primary completion within 12 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 120 mo7–105 · 21 studies——
Phase 212 mo8–31 · 24 studies——
Phase 314 mo4–29 · 17 studies——
Phase 420 mo5–35 · 18 studies——
Interventional, no phase17 mo7–33 · 175 studies—18 mo8–33 · 169 studies
Observational22 mo12–52 · 53 studies—22 mo12–52 · 52 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 12, 2026.

Started recruiting1

Results posted1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 706. Browse all 706 → or search them.